Neonatal Herpes Simplex Virus Infections

Pediatric Clinics of North America

Volumn 60, Issue 2, 2013, Pages 351-365

  Pinninti, Swetha G ^a   Kimberlin, David W ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Acyclovir; Antiviral therapy; Neonatal herpes; Polymerase chain reaction

Indexed keywords

ACICLOVIR; HERPES SIMPLEX VACCINE; PLACEBO; VALACICLOVIR; VIDARABINE;

ASYMPTOMATIC INFECTION; CENTRAL NERVOUS SYSTEM INFECTION; CESAREAN SECTION; DIFFERENTIAL DIAGNOSIS; DISABILITY; DRUG BIOAVAILABILITY; DRUG CLEARANCE; DRUG MEGADOSE; EVIDENCE BASED MEDICINE; EYE INFECTION; GENITAL HERPES; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HUMAN; INFECTION RISK; INTRAUTERINE INFECTION; LOW DRUG DOSE; MORBIDITY; MORTALITY; MOUTH INFECTION; NEUTROPENIA; NEWBORN; NEWBORN INFECTION; NEWBORN SEPSIS; NONHUMAN; PERINATAL PERIOD; POLYMERASE CHAIN REACTION; PRACTICE GUIDELINE; PROGNOSIS; RECURRENT INFECTION; REVIEW; SEROCONVERSION; SEROLOGY; SEROPREVALENCE; SYMPTOMATOLOGY; TREATMENT RESPONSE; VACCINATION; VERTICAL TRANSMISSION; VIRAL SKIN DISEASE; VIRUS IDENTIFICATION; VIRUS MORPHOLOGY; VIRUS TRANSMISSION;

ACYCLOVIR; ADULT; ANTIVIRAL AGENTS; CENTRAL NERVOUS SYSTEM VIRAL DISEASES; DEVELOPMENTAL DISABILITIES; DIAGNOSIS, DIFFERENTIAL; EVIDENCE-BASED MEDICINE; FEMALE; HERPES GENITALIS; HERPES SIMPLEX; HERPES SIMPLEX VIRUS VACCINES; HUMANS; INFANT, NEWBORN; MORBIDITY; MOTHERS; POLYMERASE CHAIN REACTION; PRACTICE GUIDELINES AS TOPIC; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PROGNOSIS; RECURRENCE; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SIMPLEXVIRUS;

EID: 84875338786     PISSN: 00313955     EISSN: 15578240     Source Type: Journal    
DOI: 10.1016/j.pcl.2012.12.005     Document Type: Review

References (52)

1. Kulhanjian J.A., Soroush V., Au D.S., et al. Identification of women at unsuspected risk of primary infection with herpes simplex virus type 2 during pregnancy. N Engl J Med 1992, 326(14):916-920.
2. Whitley R.J., Corey L., Arvin A., et al. Changing presentation of herpes simplex virus infection in neonates. J Infect Dis 1988, 158(1):109-116.
3. Brown Z.A., Selke S., Zeh J., et al. The acquisition of herpes simplex virus during pregnancy. N Engl J Med 1997, 337(8):509-515.
4. Sheffield J.S., Hill J.B., Hollier L.M., et al. Valacyclovir prophylaxis to prevent recurrent herpes at delivery: a randomized clinical trial. Obstet Gynecol 2006, 108(1):141-147.
5. Watts D.H., Brown Z.A., Money D., et al. A double-blind, randomized, placebo-controlled trial of acyclovir in late pregnancy for the reduction of herpes simplex virus shedding and cesarean delivery. Am J Obstet Gynecol 2003, 188(3):836-843.
6. Brown Z.A., Benedetti J., Ashley R., et al. Neonatal herpes simplex virus infection in relation to asymptomatic maternal infection at the time of labor. N Engl J Med 1991, 324(18):1247-1252.
7. Arvin A.M., Hensleigh P.A., Prober C.G., et al. Failure of antepartum maternal cultures to predict the infant's risk of exposure to herpes simplex virus at delivery. N Engl J Med 1986, 315(13):796-800.
8. Vontver L.A., Hickok D.E., Brown Z., et al. Recurrent genital herpes simplex virus infection in pregnancy: infant outcome and frequency of asymptomatic recurrences. Am J Obstet Gynecol 1982, 143(1):75-84.
9. Sullender W.M., Yasukawa L.L., Schwartz M., et al. Type-specific antibodies to herpes simplex virus type 2 (HSV-2) glycoprotein G in pregnant women, infants exposed to maternal HSV-2 infection at delivery, and infants with neonatal herpes. J Infect Dis 1988, 157(1):164-171.
10. Brown Z.A., Wald A., Morrow R.A., et al. Effect of serologic status and cesarean delivery on transmission rates of herpes simplex virus from mother to infant. JAMA 2003, 289(2):203-209.
11. Kimberlin D.W. Neonatal herpes simplex infection. Clin Microbiol Rev 2004, 17(1):1-13.
12. Corey L., Wald A. Maternal and neonatal herpes simplex virus infections. N Engl J Med 2009, 361(14):1376-1385.
13. Nahmias A.J., Josey W.E., Naib Z.M., et al. Perinatal risk associated with maternal genital herpes simplex virus infection. Am J Obstet Gynecol 1971, 110(6):825-837.
14. Prober C.G., Sullender W.M., Yasukawa L.L., et al. Low risk of herpes simplex virus infections in neonates exposed to the virus at the time of vaginal delivery to mothers with recurrent genital herpes simplex virus infections. N Engl J Med 1987, 316(5):240-244.
15. Yeager A.S., Arvin A.M. Reasons for the absence of a history of recurrent genital infections in mothers of neonates infected with herpes simplex virus. Pediatrics 1984, 73(2):188-193.
16. ACOG Practice Bulletin Clinical management guidelines for obstetrician-gynecologists. No. 82 June 2007. Management of herpes in pregnancy. Obstet Gynecol 2007, 109(6):1489-1498.
17. Peng J., Krause P.J., Kresch M. Neonatal herpes simplex virus infection after cesarean section with intact amniotic membranes. J Perinatol 1996, 16(5):397-399.
18. Kaye E.M., Dooling E.C. Neonatal herpes simplex meningoencephalitis associated with fetal monitor scalp electrodes. Neurology 1981, 31(8):1045-1047.
19. O'Riordan D.P., Golden W.C., Aucott S.W. Herpes simplex virus infections in preterm infants. Pediatrics 2006, 118(6):e1612-e1620.
20. Overall J.C. Herpes simplex virus infection of the fetus and newborn. Pediatr Ann 1994, 23(3):131-136.
21. Whitley R.J., Nahmias A.J., Soong S.J., et al. Vidarabine therapy of neonatal herpes simplex virus infection. Pediatrics 1980, 66(4):495-501.
22. Whitley R., Arvin A., Prober C., et al. A controlled trial comparing vidarabine with acyclovir in neonatal herpes simplex virus infection. Infectious Diseases Collaborative Antiviral Study Group. N Engl J Med 1991, 324(7):444-449.
23. Whitley R., Arvin A., Prober C., et al. Predictors of morbidity and mortality in neonates with herpes simplex virus infections. The National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. N Engl J Med 1991, 324(7):450-454.
24. Kimberlin D.W., Lin C.Y., Jacobs R.F., et al. Safety and efficacy of high-dose intravenous acyclovir in the management of neonatal herpes simplex virus infections. Pediatrics 2001, 108(2):230-238.
25. Kimberlin D.W., Lin C.Y., Jacobs R.F., et al. Natural history of neonatal herpes simplex virus infections in the acyclovir era. Pediatrics 2001, 108(2):223-229.
26. Baldwin S., Whitley R.J. Intrauterine herpes simplex virus infection. Teratology 1989, 39(1):1-10.
27. Hutto C., Arvin A., Jacobs R., et al. Intrauterine herpes simplex virus infections. J Pediatr 1987, 110(1):97-101.
28. Monif G.R., Kellner K.R., Donnelly W.H. Congenital herpes simplex type II infection. Am J Obstet Gynecol 1985, 152(8):1000-1002.
29. Pinninti S.G., Angara R., Feja K.N., et al. Neonatal herpes disease following maternal antenatal antiviral suppressive therapy: a multicenter case series. J Pediatr 2012, 161(1):134-138.e1-3.
30. Pickering L., Baker C., Kimberlin D., et al. Herpes Simplex. Red book. Report of the Committee on Infectious Diseases 2012, 398-408. American Academy of Pediatrics, Elk Grove Village (IL). 29th edition. L. Pickering (Ed.).
31. Barbi M., Binda S., Primache V., et al. Use of Guthrie cards for the early diagnosis of neonatal herpes simplex virus disease. Pediatr Infect Dis J 1998, 17(3):251-252.
32. Diamond C., Mohan K., Hobson A., et al. Viremia in neonatal herpes simplex virus infections. Pediatr Infect Dis J 1999, 18(6):487-489.
33. Kimberlin D.W., Lakeman F.D., Arvin A.M., et al. Application of the polymerase chain reaction to the diagnosis and management of neonatal herpes simplex virus disease. National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. J Infect Dis 1996, 174(6):1162-1167.
34. Kimura H., Futamura M., Kito H., et al. Detection of viral DNA in neonatal herpes simplex virus infections: frequent and prolonged presence in serum and cerebrospinal fluid. J Infect Dis 1991, 164(2):289-293.
35. Malm G., Forsgren M. Neonatal herpes simplex virus infections: HSV DNA in cerebrospinal fluid and serum. Arch Dis Child Fetal Neonatal Ed 1999, 81(1):F24-F29.
36. Atkins J.T. HSV PCR for CNS infections: pearls and pitfalls. Pediatr Infect Dis J 1999, 18(9):823-824.
37. Troendle-Atkins J., Demmler G.J., Buffone G.J. Rapid diagnosis of herpes simplex virus encephalitis by using the polymerase chain reaction. J Pediatr 1993, 123(3):376-380.
38. Lewensohn-Fuchs I., Osterwall P., Forsgren M., et al. Detection of herpes simplex virus DNA in dried blood spots making a retrospective diagnosis possible. J Clin Virol 2003, 26(1):39-48.
39. Englund J.A., Fletcher C.V., Balfour H.H. Acyclovir therapy in neonates. J Pediatr 1991, 119:129-135.
40. Caviness A.C., Demmler G.J., Almendarez Y., et al. The prevalence of neonatal herpes simplex virus infection compared with serious bacterial illness in hospitalized neonates. J Pediatr 2008, 153(2):164-169.
41. Kimberlin D.W. When should you initiate acyclovir therapy in a neonate?. J Pediatr 2008, 153(2):155-156.
42. Long S.S. In defense of empiric acyclovir therapy in certain neonates. J Pediatr 2008, 153(2):157-158.
43. Kimberlin D.W., Whitley R.J., Wan W., et al. Oral acyclovir suppression and neurodevelopment after neonatal herpes. N Engl J Med 2011, 365(14):1284-1292.
44. Kimberlin D., Powell D., Gruber W., et al. Administration of oral acyclovir suppressive therapy after neonatal herpes simplex virus disease limited to the skin, eyes and mouth: results of a phase I/II trial. Pediatr Infect Dis J 1996, 15(3):247-254.
45. Kimberlin D.W., Jacobs R.F., Weller S., et al. Pharmacokinetics and safety of extemporaneously compounded valacyclovir oral suspension in pediatric patients from 1 month through 11 years of age. Clin Infect Dis 2010, 50(2):221-228.
46. Kimberlin DW, Brady MT, Byington MT, et al. American Academy of Pediatrics Committee on Infectious Diseases, in conjunction with COFN and ACOG: Policy Statement - Guidance on management of neonates born to women with active genital herpes lesions. in press.
47. Roberts S.W., Cox S.M., Dax J., et al. Genital herpes during pregnancy: no lesions, no cesarean. Obstet Gynecol 1995, 85(2):261-264.
48. Stone K.M., Reiff-Eldridge R., White A.D., et al. Pregnancy outcomes following systemic prenatal acyclovir exposure: conclusions from the international acyclovir pregnancy registry, 1984-1999. Birth Defects Res A Clin Mol Teratol 2004, 70(4):201-207.
49. Stanberry L.R., Spruance S.L., Cunningham A.L., et al. Glycoprotein-D-adjuvant vaccine to prevent genital herpes. N Engl J Med 2002, 347(21):1652-1661.
50. Belshe R.B., Leone P.A., Bernstein D.I., et al. Efficacy results of a trial of a herpes simplex vaccine. N Engl J Med 2012, 366(1):34-43.
51. Brown Z.A., Gardella C., Wald A., et al. Genital herpes complicating pregnancy. Obstet Gynecol 2005, 106(4):845-856.
52. Centers for Disease Control and Prevention (CDC) Neonatal herpes simplex virus infection following Jewish ritual circumcisions that included direct orogenital suction-New York City, 2000-2011. MMWR Morb Mortal Wkly Rep 2012, 61:405-409.